BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 3876976)

  • 1. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
    Sausville EA; Worsham GF; Matthews MJ; Makuch RW; Fischmann AB; Schechter GP; Gazdar AF; Bunn PA
    Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
    Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides.
    Lynch JW; Linoilla I; Sausville EA; Steinberg SM; Ghosh BC; Nguyen DT; Schechter GP; Fischmann AB; Ihde DC; Stocker JL
    Blood; 1992 Jun; 79(12):3293-9. PubMed ID: 1596570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
    Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE
    Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
    Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
    Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
    Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
    Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
    Tsai EY; Taur A; Espinosa L; Quon A; Johnson D; Dick S; Chow S; Advani R; Warnke R; Kohler S; Hoppe RT; Kim YH
    Arch Dermatol; 2006 May; 142(5):577-84. PubMed ID: 16702495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node biopsy in mycosis fungoides.
    Colby TV; Burke JS; Hoppe RT
    Cancer; 1981 Jan; 47(2):351-9. PubMed ID: 7459823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
    Wechsler J; Diebold J; Gerard-Marchant R
    Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.
    Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G
    Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy.
    Schechter GP; Bunn PA; Fischmann AB; Matthews MJ; Guccion J; Soehnlen F; Munson D; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):571-4. PubMed ID: 312694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical staging for cutaneous T-cell lymphoma.
    Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Douglas MC; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL
    Ann Intern Med; 1984 Feb; 100(2):187-92. PubMed ID: 6607008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome.
    Graham SJ; Sharpe RW; Steinberg SM; Cotelingam JD; Sausville EA; Foss FM
    Cancer; 1993 Aug; 72(3):726-34. PubMed ID: 8334625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
    Dmitrovsky E; Matthews MJ; Bunn PA; Schechter GP; Makuch RW; Winkler CF; Eddy J; Sausville EA; Ihde DC
    J Clin Oncol; 1987 Feb; 5(2):208-15. PubMed ID: 3492594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
    Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
    Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.